Rizzo A - Search Results

1

Durvalumab in advanced cholangiocarcinoma: is someone knocking down the door?

Ricci AD, D'Alessandro R, Rizzo A, Schirizzi A, Vallarelli S, Ostuni C, Troiani L, Lolli IR, Lotesoriere C, Giannelli G. Ricci AD, et al. Among authors: rizzo a. Immunotherapy. 2023 May;15(7):477-486. doi: 10.2217/imt-2022-0301. Epub 2023 Mar 23. Immunotherapy. 2023. PMID: 36950960 Review.

2

Third- and later-line treatment in advanced or metastatic gastric cancer: a systematic review and meta-analysis.

Rizzo A, Mollica V, Ricci AD, Maggio I, Massucci M, Rojas Limpe FL, Fabio FD, Ardizzoni A. Rizzo A, et al. Future Oncol. 2020 Jan;16(2):4409-4418. doi: 10.2217/fon-2019-0429. Epub 2019 Dec 3. Future Oncol. 2020. PMID: 31793342

3

Anti-EGFR Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-analysis.

Rizzo A, Frega G, Ricci AD, Palloni A, Abbati F, DE Lorenzo S, Deserti M, Tavolari S, Brandi G. Rizzo A, et al. In Vivo. 2020 Mar-Apr;34(2):479-488. doi: 10.21873/invivo.11798. In Vivo. 2020. PMID: 32111744 Free PMC article.

4

Recurrent Uterine Smooth-Muscle Tumors of Uncertain Malignant Potential (STUMP): State of The Art.

Rizzo A, Ricci AD, Saponara M, DE Leo A, Perrone AM, DE Iaco P, Pantaleo MA, Nannini M. Rizzo A, et al. Anticancer Res. 2020 Mar;40(3):1229-1238. doi: 10.21873/anticanres.14064. Anticancer Res. 2020. PMID: 32132019 Review.

5

Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow.

Rizzo A, Ricci AD, Tober N, Nigro MC, Mosca M, Palloni A, Abbati F, Frega G, DE Lorenzo S, Tavolari S, Brandi G. Rizzo A, et al. Anticancer Res. 2020 Jun;40(6):3013-3030. doi: 10.21873/anticanres.14282. Anticancer Res. 2020. PMID: 32487595 Review.

6

Regarding "HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer".

Rizzo A, Ricci AD, Brandi G. Rizzo A, et al. Oncologist. 2020 Nov;25(11):e1818. doi: 10.1634/theoncologist.2020-0385. Epub 2020 Aug 13. Oncologist. 2020. PMID: 32715579 Free PMC article. No abstract available.

7

Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases?

Brandi G, Ricci AD, Rizzo A, Zanfi C, Tavolari S, Palloni A, De Lorenzo S, Ravaioli M, Cescon M. Brandi G, et al. Among authors: rizzo a. Cancer Commun (Lond). 2020 Sep;40(9):461-464. doi: 10.1002/cac2.12072. Epub 2020 Aug 6. Cancer Commun (Lond). 2020. PMID: 32762027 Free PMC article. No abstract available.

8

Systemic adjuvant treatment in hepatocellular carcinoma: tempted to do something rather than nothing.

Rizzo A, Ricci AD, Brandi G. Rizzo A, et al. Future Oncol. 2020 Nov;16(32):2587-2589. doi: 10.2217/fon-2020-0669. Epub 2020 Aug 8. Future Oncol. 2020. PMID: 32772560 No abstract available.

9

Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look.

Ricci AD, Rizzo A, Brandi G. Ricci AD, et al. Among authors: rizzo a. Cancer Control. 2020 Jul-Aug;27(3):1073274820948047. doi: 10.1177/1073274820948047. Cancer Control. 2020. PMID: 32806956 Free PMC article.

10

Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives.

Rizzo A, Ricci AD, Tavolari S, Brandi G. Rizzo A, et al. Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):441-452. doi: 10.21873/cgp.20203. Cancer Genomics Proteomics. 2020. PMID: 32859625 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,997 results

Search Page

Filters